US Patent Issued to APR APPLIED PHARMA RESEARCH on Oct. 14 for "Modified release orally administered amino acid formulations" (Italian Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,463, issued on Oct. 14, was assigned to APR APPLIED PHARMA RESEARCH S.A. (Balerna, Switzerland).

"Modified release orally administered amino acid formulations" was invented by Alberto Reiner (Como, Italy) and Giorgio Reiner (Como, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and formulations of modified release amino acids are provided for the treatment or management of diseases defined by impaired amino acid metabolism, with improved pharmacokinetics, metabolism and utilization."

The patent was filed on April 27, 2022, under Application No. 17/660,999.

*For further information, including images, charts and tables, please visit: ht...